Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-01-10
DOI
10.3389/fimmu.2017.01911
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CSPG4: a prototype oncoantigen for translational immunotherapy studies
- (2017) Valeria Rolih et al. Journal of Translational Medicine
- BRAF inhibitors: resistance and the promise of combination treatments for melanoma
- (2017) Merope Griffin et al. Oncotarget
- A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion protein
- (2016) Manal Amoury et al. INTERNATIONAL JOURNAL OF CANCER
- The application of local hypobaric pressure — A novel means to enhance macromolecule entry into the skin
- (2016) R. Inacio et al. JOURNAL OF CONTROLLED RELEASE
- NG2 Proteoglycan-Dependent Contributions of Pericytes and Macrophages to Brain Tumor Vascularization and Progression
- (2016) William B. Stallcup et al. MICROCIRCULATION
- The Role of NG2 Proteoglycan in Glioma
- (2016) Sridevi Yadavilli et al. Translational Oncology
- Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demand
- (2016) Manal Amoury et al. Oncotarget
- Mesenchymal Tumors Can Derive from Ng2/Cspg4-Expressing Pericytes with β-Catenin Modulating the Neoplastic Phenotype
- (2016) Shingo Sato et al. Cell Reports
- NG2-glia and their functions in the central nervous system
- (2015) L. Dimou et al. GLIA
- Anti-chondroitin sulfate proteoglycan 4-specific antibodies modify the effects of vemurafenib on melanoma cells differentially in normoxia and hypoxia
- (2015) DANIELA PUCCIARELLI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Stonin1 mediates endocytosis of the proteoglycan NG2 and regulates focal adhesion dynamics and cell motility
- (2015) Fabian Feutlinske et al. Nature Communications
- The emerging role of NG2 in pediatric diffuse intrinsic pontine glioma
- (2015) Sridevi Yadavilli et al. Oncotarget
- Theranostic Impact of NG2/CSPG4 Proteoglycan in Cancer
- (2015) Pier Andrea Nicolosi et al. Theranostics
- Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival
- (2015) Aurelie Poli et al. Oncotarget
- Reduced promoter methylation and increased expression of CSPG4 negatively influences survival of HNSCC patients
- (2014) Rolf Warta et al. INTERNATIONAL JOURNAL OF CANCER
- Recombinant DNA Technology for Melanoma Immunotherapy: Anti-Id DNA Vaccines Targeting High Molecular Weight Melanoma-Associated Antigen
- (2014) A. Barucca et al. MOLECULAR BIOTECHNOLOGY
- Effects of BRAF Mutations and BRAF Inhibition on Immune Responses to Melanoma
- (2014) K. M. Ilieva et al. MOLECULAR CANCER THERAPEUTICS
- Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer
- (2014) N B Volz et al. PHARMACOGENOMICS JOURNAL
- Oligodendrocyte Precursor Cells Modulate the Neuronal Network by Activity-Dependent Ectodomain Cleavage of Glial NG2
- (2014) Dominik Sakry et al. PLOS BIOLOGY
- Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells
- (2014) Rachel E Beard et al. Journal for ImmunoTherapy of Cancer
- High chondroitin sulfate proteoglycan 4 expression correlates with poor outcome in patients with breast cancer
- (2013) Nicholas C. Hsu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both In Vitro and In Vivo
- (2013) C. Geldres et al. CLINICAL CANCER RESEARCH
- Gene Expression Profiling using Nanostring Digital RNA Counting to Identify Potential Target Antigens for Melanoma Immunotherapy
- (2013) R. E. Beard et al. CLINICAL CANCER RESEARCH
- Proteoglycans and their roles in brain cancer
- (2013) Anna Wade et al. FEBS Journal
- General overview of radioimmunotherapy of solid tumors
- (2013) Isabelle Navarro-Teulon et al. Immunotherapy
- IgG4 subclass antibodies impair antitumor immunity in melanoma
- (2013) Panagiotis Karagiannis et al. JOURNAL OF CLINICAL INVESTIGATION
- Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain
- (2013) Ethan G Hughes et al. NATURE NEUROSCIENCE
- The chrondroitin sulfate proteoglycan (CSPG4) regulates human trophoblast function
- (2013) M. Van Sinderen et al. PLACENTA
- Cell-Surface Expression of Neuron-Glial Antigen 2 (NG2) and Melanoma Cell Adhesion Molecule (CD146) in Heterogeneous Cultures of Marrow-Derived Mesenchymal Stem Cells
- (2013) Katie C. Russell et al. TISSUE ENGINEERING PART A
- NG2/CSPG4-collagen type VI interplays putatively involved in the microenvironmental control of tumour engraftment and local expansion
- (2013) S. Cattaruzza et al. Journal of Molecular Cell Biology
- CSPG4 as a Target of Antibody-Based Immunotherapy for Malignant Mesothelioma
- (2012) Z. Rivera et al. CLINICAL CANCER RESEARCH
- Functional Characterization of an scFv-Fc Antibody that Immunotherapeutically Targets the Common Cancer Cell Surface Proteoglycan CSPG4
- (2011) X. Wang et al. CANCER RESEARCH
- New perspectives on APC control of cell fate and proliferation in colorectal cancer
- (2011) Reid A. Phelps et al. CELL CYCLE
- The CSPG4-specific monoclonal antibody enhances and prolongs the effects of the BRAF inhibitor in melanoma cells
- (2011) Ling Yu et al. IMMUNOLOGIC RESEARCH
- Analysis of patient survival in a Phase I trial of systemic targeted α-therapy for metastatic melanoma
- (2011) Barry J Allen et al. Immunotherapy
- Redirected Lysis of Human Melanoma Cells by a MCSP/CD3-bispecific BiTE Antibody That Engages Patient-derived T Cells
- (2011) Hitoe Torisu-Itakura et al. JOURNAL OF IMMUNOTHERAPY
- Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells
- (2011) Y Cheli et al. ONCOGENE
- CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma
- (2011) Matthew A. Price et al. Pigment Cell & Melanoma Research
- Targeting the NG2/CSPG4 Proteoglycan Retards Tumour Growth and Angiogenesis in Preclinical Models of GBM and Melanoma
- (2011) Jian Wang et al. PLoS One
- Epitope distance to the target cell membrane and antigen size determine the potency of T cell-mediated lysis by BiTE antibodies specific for a large melanoma surface antigen
- (2010) Claudia Bluemel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A High Molecular Weight Melanoma-Associated Antigen-Specific Chimeric Antigen Receptor Redirects Lymphocytes to Target Human Melanomas
- (2010) W. R. Burns et al. CANCER RESEARCH
- Enhanced Tumor Trafficking of GD2 Chimeric Antigen Receptor T Cells by Expression of the Chemokine Receptor CCR2b
- (2010) John A. Craddock et al. JOURNAL OF IMMUNOTHERAPY
- CSPG4 Protein as a New Target for the Antibody-Based Immunotherapy of Triple-Negative Breast Cancer
- (2010) Xinhui Wang et al. JNCI-Journal of the National Cancer Institute
- Melanoma-associated Chondroitin Sulfate Proteoglycan (MCSP)-targeted delivery of soluble TRAIL potently inhibits melanoma outgrowth in vitro and in vivo
- (2010) Marco de Bruyn et al. Molecular Cancer
- Selectins promote tumor metastasis
- (2010) Heinz Läubli et al. SEMINARS IN CANCER BIOLOGY
- Melanoma Proteoglycan Modifies Gene Expression to Stimulate Tumor Cell Motility, Growth, and Epithelial-to-Mesenchymal Transition
- (2009) J. Yang et al. CANCER RESEARCH
- Human bone marrow mesenchymal cells express NG2: possible increase in discriminative ability of flow cytometry during mesenchymal stromal cell identification
- (2009) Ilknur Kozanoglu et al. CYTOTHERAPY
- The NG2 proteoglycan promotes oligodendrocyte progenitor proliferation and developmental myelination
- (2009) K. Kucharova et al. NEUROSCIENCE
- NG2, a member of chondroitin sulfate proteoglycans family mediates the inflammatory response of activated microglia
- (2009) Q. Gao et al. NEUROSCIENCE
- Targeting 11q23 positive acute leukemia cells with high molecular weight-melanoma associated antigen-specific monoclonal antibodies
- (2008) Allison S. Drake et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Loss of E-Cadherin Promotes Metastasis via Multiple Downstream Transcriptional Pathways
- (2008) T. T. Onder et al. CANCER RESEARCH
- FGF2-dependent neovascularization of subcutaneous Matrigel plugs is initiated by bone marrow-derived pericytes and macrophages
- (2008) U. Tigges et al. DEVELOPMENT
- NG2 expression predicts the metastasis formation in soft-tissue sarcoma patients
- (2008) Maria Serena Benassi et al. JOURNAL OF ORTHOPAEDIC RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search